l 636499 has been researched along with 2,3-dinor-thromboxane b2 in 1 studies
| Studies (l 636499) | Trials (l 636499) | Recent Studies (post-2010) (l 636499) | Studies (2,3-dinor-thromboxane b2) | Trials (2,3-dinor-thromboxane b2) | Recent Studies (post-2010) (2,3-dinor-thromboxane b2) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 154 | 20 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fitzgerald, DJ; FitzGerald, GA; Fragetta, J | 1 |
1 other study(ies) available for l 636499 and 2,3-dinor-thromboxane b2
| Article | Year |
|---|---|
Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Coronary Disease; Coronary Thrombosis; Dibenzothiepins; Dogs; Male; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Thromboxane B2; Thromboxane-A Synthase | 1988 |